Angiotensin-converting enzyme 2: virus accomplice or host defender?

Author:

Wang Jiyan1,Chang Hongkai1,Qiao Yaya1,Sun Huanran1,Li Xichuan2,Yuan Shuofeng3,Zhang Shuai4,Shan Changliang1

Affiliation:

1. State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, China

2. Tianjin Key Laboratory of Animal and Plant Resistance, College of Life Sciences, Tianjin Normal University, Tianjin 300387, China

3. State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam 999077, Hong Kong Special Administrative Region, China

4. School of Integrative Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China

Abstract

Objective: Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to social disruptions, mainly because we know too little about SARS-CoV-2. Methods and Results: In this study, we integrated RNA sequencing results and found that SARS-CoV-2 infection alters aerobic glycolysis, the oxidative pentose phosphate pathway (oxiPPP), and DNA replication in lung tissues and cells. However, the direction of metabolic flux and DNA replication are dominated by angiotensin-converting enzyme 2 (ACE2), a host cell-expressed viral receptor protein. More interestingly, although hosts with a high expression of ACE2 are more likely to be infected with SARS-CoV-2, the invading virus cannot perform nucleic acid replication well due to the restriction of glucose metabolism, eventually resulting in a prolonged infection cycle or infection failure. Conclusion: Our findings preliminarily explain the reasons for the emergence of asymptomatic infections at an early stage, which will provide assistance for the development of detection methods for diagnosing COVID-19.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Computer Science Applications,General Biochemistry, Genetics and Molecular Biology,Biomedical Engineering

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3